These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8632771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
    Benya RV, Akeson M, Mrozinski J, Jensen RT, Battey JF.
    Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
    [Abstract] [Full Text] [Related]

  • 5. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
    Labbé-Jullié C, Botto JM, Mas MV, Chabry J, Mazella J, Vincent JP, Gully D, Maffrand JP, Kitabgi P.
    Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
    [Abstract] [Full Text] [Related]

  • 6. Differential involvement of intracellular domains of the rat NTS1 neurotensin receptor in coupling to G proteins: a molecular basis for agonist-directed trafficking of receptor stimulus.
    Skrzydelski D, Lhiaubet AM, Lebeau A, Forgez P, Yamada M, Hermans E, Rostene W, Pelaprat D.
    Mol Pharmacol; 2003 Aug; 64(2):421-9. PubMed ID: 12869647
    [Abstract] [Full Text] [Related]

  • 7. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL, Fouraux MA, Pouwels W, van Emst-de Vries SE, Ronken E, De Pont JJ, Willems PH.
    Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
    [Abstract] [Full Text] [Related]

  • 8. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
    Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M, Steinberg R, Suaud-Chagny MF, Santucci V, Vita N, Pecceu F, Labbé-Jullié C, Kitabgi P, Soubrié P, Le Fur G, Maffrand JP.
    J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
    Lee NH, Geoghagen NS, Cheng E, Cline RT, Fraser CM.
    Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
    [Abstract] [Full Text] [Related]

  • 14. Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses.
    Brodbeck RM, Sachais BS, Krause JE.
    Mol Pharmacol; 1995 May; 47(5):1065-71. PubMed ID: 7538194
    [Abstract] [Full Text] [Related]

  • 15. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I, Gaspard N, Langlet C, Robberecht P, Langer I.
    Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
    [Abstract] [Full Text] [Related]

  • 16. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M, Dragatsis I, Megaritis G, Konidakis G, Zioudrou C, Milligan G, Georgoussi Z.
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [Abstract] [Full Text] [Related]

  • 17. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
    Laporte SA, Servant G, Richard DE, Escher E, Guillemette G, Leduc R.
    Mol Pharmacol; 1996 Jan; 49(1):89-95. PubMed ID: 8569717
    [Abstract] [Full Text] [Related]

  • 18. Structural determinants of agonist-induced signaling and regulation of the angiotensin AT1 receptor.
    Hunyady L, Gáborik Z, Shah BH, Jagadeesh G, Clark AJ, Catt KJ.
    Mol Cell Endocrinol; 2004 Mar 31; 217(1-2):89-100. PubMed ID: 15134806
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2.
    Yamada M, Ohata H, Momose K, Yamada M, Richelson E.
    Res Commun Mol Pathol Pharmacol; 1995 Oct 31; 90(1):37-47. PubMed ID: 8581347
    [Abstract] [Full Text] [Related]

  • 20. Lack of constitutive activation or inactivation of the platelet-activating factor receptor by glutamate substitution of alanine 230.
    Carlson SA, Chatterjee TK, Fisher RA.
    Recept Signal Transduct; 1996 Oct 31; 6(2):111-20. PubMed ID: 9015866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.